How to appeal a UnitedHealthcare cardiology drugs denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for cardiology drugs

Cited policy: OptumRx PCSK9 Inhibitor Prior Authorization (Repatha/Praluent)

Step therapy: max-tolerated statin + ezetimibe trial >=12 weeks. Very-high-risk ASCVD LDL>=70 OR HeFH primary prevention LDL>=100. Specialist Rx (cardiologist or lipidologist) often required.

How UnitedHealthcare denies cardiology drugs — and how to counter it

Where UnitedHealthcare pushes back: 1) Step therapy not satisfied (no ezetimibe); 2) LDL doesn't meet threshold; 3) Diagnosis code mismatch.

Counter-arguments that hold up: Cite 2022 ACC Expert Consensus on PCSK9 LDL threshold. Document ezetimibe trial dates+doses or intolerance. Map ICD-10 specifically to ASCVD events (I21.x, I63.x, I73.9). FOURIER trial NEJM 2017.

What UnitedHealthcare typically denies for cardiology drugs

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For cardiology drugs, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the cardiology drugs treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Repatha
• Praluent
• Leqvio
• Entresto
• SGLT2i for HF
• Verquvo

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.